Conference Coverage
Latest News
Shorts






Videos
Ophthalmology Times Europe Digital Edition




Continuing Medical Education
All News

Dr Khanani shared his first-time results talk during an AAO specialty day

At the 2025 Academy of American Ophthalmology meeting, Prof Stalmans described safety and efficacy benefits of disposable non-contact vitrectomy lenses

Dr Borkar, a vitreoretinal surgeon at Duke University, spoke to the Eye Care Network about her American Academy of Ophthalmology (AAO) presentation

The investigators noted that this report is the first about subretinal drusenoid deposits in Black and Hispanic patients with age-related macular degeneration

Jean-Francois Korobelnik, MD, shares highlights from the PULSAR extension study showcasing aflibercept 8 mg and its ability to promote fluid resolution

The video-driven platform will improve workflow, education and engagement, said Inder Paul Singh, MD

The full range of vision lens debuted at the 2025 ESCRS meeting in Copenhagen

Patients with proliferative diabetic retinopathy, central retinal vein occlusion and branch retinal vein occlusion experienced fluctuating retinal perfusion, investigators reported

Dr Chhablani said "having multiple approaches to the same problem" is key for reaching the maximum number of patients with age-related macular degeneration

The agenda includes subspecialty days, evening events and partner programmes from practice management organisations

Research finding challenge the widely-held notion that cosmetic contact lenses are the safest technique for changing eye colour

A pair of studies, conducted in Taiwan and China, indicate that red light therapy could serve as an effective and safe alternative to atropine

Biomarkers and fine-tuned staging are key to progress in improving retinal care, according to Fanka Gilevska, MD, PhD

Patient response focused on perceived vision-related quality of life outcomes, investigators said

Dr Miere presented the ACTOR study, illuminating vascular remodeling in patients with neovascular AMD, and the HERMES study, investigating perfusion changes in central retinal vein occlusion

María Berrocal, MD, spoke about the Vit-Buckle Society (VBS), which has become a regular feature at the European Society of Retina Specialists annual meeting

The procurement follows an 18-month pilot at a high-volume surgery in Dundee, Scotland

Prof Romano stressed the importance of matching procedure to patient, not just mastering technical vitrectomy skills

EyeArt uses artificial intelligence for autonomous detection of vision-threatening diabetic retinopathy

The newly-approved technology delivers low-dose microcurrents through closed eyelids to stimulate retinal cells

Today, over 150 practitioners from 20 countries in Australia, Asia and Europe enter their patient data into the Fight Retinal Blindness! Registry

The current staging system fails to fully capture the neurovascular unit's status, said Stela Vujosevic, Md, PhD, FEBO

At the EURETINA congress, Prof Boon discussed controversies in treatment, some driven by critical prospective studies

Alteogen received a positive CHMP opinion for EYLUXVI in July 2025


Leading companies spotlight innovations in cataract and refractive surgery at the 43rd ESCRS Congress in Copenhagen

Artificial intelligence is quickly expanding the breadth and depth of information clinicians can interpret, Prof Uy said

At the ESCRS meeting, cataract surgeons can get familiar with BVI's Virtuoso platform and VirtuaLens' immersive VR IOL simulator

Alcon, Bausch + Lomb and Johnson & Johnson will debut new research findings during the European Society of Cataract and Refractive Surgeons Congress in Copenhagen, Denmark

Ahead of the ESCRS congress and iNovation day, we go behind the scenes with Ciliatech founder Philippe Sourdille, MD, and president Olivier Benoit

Prof Stanzel detailed new advancements in proliferative vitreoretinopathy and a hyperaspheric IOL designed for patients with age-related macular degeneration

Dr Ramtohul's research uses electrophysiologic testing to study the retinal ganglion cells

The US Food and Drug Administration (FDA) also granted RMAT designation for MCO-010 in Stargardt disease (SD).






































































